Printer Friendly

Clarinol[TM] conjugated linoleic acid (CLA). (Raw Material Research).

Raw Material: Clarinol[TM] conjugated linoleic acid (CLA)

Indication: Immunity

Source: NIH Conference, May 2002

Research: Using the hepatitis B vaccination as an infection model, 75 human subjects were divided into three treatment groups that were supplemented for a 13 week period. The groups included a control group and two CLA groups that received two different ratios of the naturally occurring isomers c9,t11 and t10, c12--one group at the ratio of 50:50 and the other group at the ratio of 80:20.

Results: Those who received CLA supplementation with equal (50:50) concentrations of the active isomers performed significantly better than those in the control group or the other experimental group. In fact, at the conclusion of the study the antibody level in those who received CLA with c9, t11 and t10, c12 in a 50:50 ratio was twice as high as those who received CLA with those isomers in an 80:20 ratio or those who received no CLA at all.
COPYRIGHT 2002 Rodman Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nutraceuticals World
Article Type:Brief Article
Geographic Code:1USA
Date:Sep 1, 2002
Words:165
Previous Article:Antioxidants. (Raw Material Research).
Next Article:L-carnitine L-tartrate (LCLT). (Raw Material Research).
Topics:


Related Articles
This fat may fight cancer several ways.
Fat as a taste: modifying behavior in rats with linoleic acid. (South Carolina Junior Academy Of Sciences Abstracts).
Cognis, Natural ASA agreement goes into effect. (Industry News).
Nutraceuticals Research.
Conjugated linoleic acid (CLA).
Conjugated linoleic acid (CLA).
Conjugated linoleic acid (as Tonalin CLA) in skim milk.
CLA and exercise improve body composition.
Creatine, CLA strengthen exercise in seniors.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |